Results 71 to 80 of about 5,177 (179)

Resistance of mice immunized with killed culture trypomastigotes against infection by insect-derived trypomastigotes of Trypanosoma cruzi Resistência de camundongos imunizados com tripomastigotas de cultura mortos contra infecção por tripomastigotas de Trypanosoma cruzi provenientes do inseto

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1984
Mice immunized with heat or merthiolate-killed culture trypomastigotes of the non-virulent G strain were resistant to the challenge by insect-derived trypomastigotes of the CL strain of Trypanosoma cruzi.
N. Yoshida   +3 more
doaj  

Early and late molecular and morphologic changes that occur during the in vitro transformation of Trypanosoma cruzi metacyclic trypomastigotes to amastigotes

open access: yesBiological Research, 2002
The amastigogenesis primary of T. cruzi occurs naturally when metacyclic trypomastigotes transform into amastigotes within the cells of the mammalian host.
VÍCTOR T CONTRERAS   +5 more
doaj  

Trypanosoma cruzi: behavior of metatrypomastigotes from didelphis marsupialis and panstrongylus geniculatus

open access: yesRevista Científica, 2010
Trypanosoma cruz; colonizes the anal scent glands of Didelphis marsupialis opossum, differentiating into metatryposmastigotes, which affect mammals through contamination in the same way as do metacyclics formed in the stomach of the triatomine vector.
Leidi Herrera   +2 more
doaj  

In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist
Baek KH   +6 more
europepmc   +1 more source

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination. [PDF]

open access: yesNPJ Antimicrob Resist
Francisco AF   +4 more
europepmc   +1 more source

Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity. [PDF]

open access: yesPLoS Negl Trop Dis
Mengarda AC   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy